Table 3.
Summary of outcomes
Analysis | Cost: PM | Cost: ICM | QALYs: PM | QALYs: ICM | ICER |
---|---|---|---|---|---|
Trial evaluation (2-y time horizon) | $9806 | $13,483 | –0.021 | –0.046 | PM dominates |
Decision analytic model (3-y time horizon) | $9934 | $15,500 | –0.031 | –0.134 | PM dominates |
Costs are given in Canadian dollars.
ICER, incremental cost-effectiveness ratio; ICM, implantable cardiac monitor; PM, pacemaker; QALY, quality-adjusted life-year.